DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Debiec-Rychter M, Sciot R, Le Cesne A et al.
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.
Eur J Cancer 2006;
42: 1093-1103
We do not assume any responsibility for the contents of the web pages of other providers.